BMP-2, BMPRIB, and BMPRII may play a part in the occurrence and development of ovarian cancer, and the variation or loss of expression of BMP-2, BMPRIB, and BMPRII may be an indicator of poor prognosis for ovarian cancer patients. Here, BMPR2 is linked to ovarian cancer.